InvestorsObserver
×
News Home

Do Traders Think Berkeley Lights Inc (BLI) Can Keep Climbing Monday?

Monday, August 15, 2022 03:51 PM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Berkeley Lights Inc (BLI) Can Keep Climbing Monday?

Berkeley Lights Inc (BLI) stock is higher by 1.35% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,neutral
Berkeley Lights Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on BLI!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With BLI Stock Today?

Berkeley Lights Inc (BLI) stock is trading at $5.25 as of 3:42 PM on Monday, Aug 15, an increase of $0.03, or 0.48% from the previous closing price of $5.22. Volume today is 1,032,701 compared to average volume of 839,320. The stock has traded between $5.08 and $5.47 so far today. To see InvestorsObserver's Sentiment Score for Berkeley Lights Inc click here.

More About Berkeley Lights Inc

Berkeley Lights Inc is a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. The Berkeley Lights Platform is a fully integrated, end-to-end solution, comprised of proprietary consumables, including its OptoSelect chips and reagent kits, advanced automation systems, and advanced application and workflow software. The company operates in North America, Asia Pacific, and Europe, with North America deriving nearly half of the revenue. Click Here to get the full Stock Report for Berkeley Lights Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App